Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other financing activities (2016 - 2018)

Historic Other financing activities for Assembly Biosciences (ASMB) over the last 4 years, with Q3 2018 value amounting to -$543780.0.

  • Assembly Biosciences' Other financing activities fell 45184.24% to -$543780.0 in Q3 2018 from the same period last year, while for Sep 2018 it was -$524726.0, marking a year-over-year decrease of 13803.03%. This contributed to the annual value of -$84192.0 for FY2017, which is 4463.99% down from last year.
  • Assembly Biosciences' Other financing activities amounted to -$543780.0 in Q3 2018, which was down 45184.24% from $18857.0 recorded in Q2 2018.
  • Assembly Biosciences' Other financing activities' 5-year high stood at $86231.0 during Q4 2017, with a 5-year trough of -$543780.0 in Q3 2018.
  • Moreover, its 4-year median value for Other financing activities was -$27032.0 (2015), whereas its average is -$63494.7.
  • As far as peak fluctuations go, Assembly Biosciences' Other financing activities skyrocketed by 29331.55% in 2017, and later plummeted by 72497.46% in 2018.
  • Quarter analysis of 4 years shows Assembly Biosciences' Other financing activities stood at -$27032.0 in 2015, then tumbled by 85.05% to -$50022.0 in 2016, then skyrocketed by 272.39% to $86231.0 in 2017, then crashed by 730.61% to -$543780.0 in 2018.
  • Its Other financing activities was -$543780.0 in Q3 2018, compared to $18857.0 in Q2 2018 and -$86034.0 in Q1 2018.